Merck smart insulin project advancing into clinical trials

On May 6, 2014, Merck held an investor briefing and provided updates on various strategic initiatives, including its smart insulin project acquired in 2010 when it purchased SmartCells. SmartCells — a diabetes drug-development company that received early support from JDRF — was founded in 2003 by Todd Zion, Ph.D., an MIT chemical engineer who had […]

Volunteer Spotlight: Dayton Coles

Relaying the Research One thing we can all agree on – T1D is a complicated disease. It is not easy for the general public to understand and the science behind the research is sometimes difficult to explain. But it is vital that we get the word out: JDRF is funding research that will improve the […]

Leader of the pack

There’s a reason Mike Pack is beaming with pride at Advance Auto Parts’ contribution to JDRF. When Mike Pack sold his first JDRF Paper Sneaker, he couldn’t imagine how significant an impact that small donation could have. It was 1996, and Mike had just started working as general manager in an Advance Auto Parts store […]

Redefining the Diagnosis of Type 1 Diabetes

Updated criteria could open new possibilities for intervention before symptoms appear JDRF is leading a pertinent discussion in the diabetes field about what defines a diagnosis of type 1 diabetes (T1D). At the 14th Annual Rachmiel Levine Diabetes and Obesity Symposium today, Richard Insel, M.D., JDRF’s chief scientific officer, reviewed evidence supporting the need to […]

Volunteer Spotlight: Kathy Stewart

A warm embrace Kathy Stewart doesn’t do anything half-heartedly. No Mentor Program? She’ll start one!  Need the Outreach Program to grow? She’ll do it! Or maybe you just need a compassionate ear after being newly diagnosed with T1D. She’ll give you her undivided attention. Ever since Kathy’s grandson Marston was diagnosed with T1D at just 14 […]

Potential drugs for beta cell regeneration discovered

At the April 2014 JDRF-GNF (Genomics Institute of the Novartis Research Foundation) meeting, Dr. Byran Laffitte described how GNF has the potential to identify the first disease altering therapy for T1D. He presented preclinical evidence that GNF has identified the first highly effective low molecular weight regulators of beta cell proliferation. Overall, GNF has identified […]

Volunteer Spotlight: Monica Oxenreiter

Check out this resume: Founder of Zip the Cure, JDRF Youth Ambassador, Walk to Cure Diabetes participant, Trial Net liaison, Promise to Remember Me Campaign advocate, JDRF Children’s Congress delegate, and regular public speaker on living with type 1 diabetes (T1D). It’s hard to believe that someone could offer so much before the age of […]

Volunteer spotlight: Brian McIntosh

Brian McIntosh is the kind of good-natured person who is often heard saying, “What needs to be done? Just tell me.” Driven by the JDRF mission to find a cure for type 1 diabetes (T1D), he is always the first one to step in when help is needed. He motivates others by demonstrating the value of service to his community.

Progress on ViaCyte’s novel encapsulated cell therapy

In February, JDRF announced it is providing additional milestone-based funding for the continued development of ViaCyte’s VC-01™ encapsulated cell therapy product candidate for the treatment of T1D. JDRF will fund up to $7 million to help ensure a rapid transition of the project into the clinical phase of development once ViaCyte’s investigational new drug application […]